LACTNET Archives

Lactation Information and Discussion

LACTNET@COMMUNITY.LSOFT.COM

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Pamela Morrison <[log in to unmask]>
Reply To:
Lactation Information and Discussion <[log in to unmask]>
Date:
Sun, 23 Dec 2012 23:30:53 +0000
Content-Type:
text/plain
Parts/Attachments:
text/plain (201 lines)
Hi Germaine

My apologies for taking a couple of days to reply 
to your message.  Going back through previous 
reviews I've made of HIV and breastfeeding, I hope the following will help:

Transmission of HIV through exclusive 
breastfeeding where the mother did not receive any antiretroviral medications:
In 1999 and 2005, research results from South 
Africa and Zimbabwe, where mothers did not 
receive antiretroviral medications, showed that 
on testing at 6 months, the risk of HIV 
transmission which could be attributed to 
exclusive breastfeeding for babies from birth to 
3 months (ie for babies who received no other 
foods or liquids besides breastmilk) was 0% and 
1.3% respectively.[1] [2] Exclusive breastfeeding 
from 0-3 months was also shown to confer a 
reduced risk of transmission during continued 
mixed breastfeeding after 3 months; rates of 
transmission from 6  15 months [3] or 6  18 
months [2] for these babies were 5.3%, and 5.6% 
respectively, whereas for the babies mixed fed 
from birth they were 9.8% and 9.5%, to achieve in 
both studies a reduced risk of transmission 
during later mixed breastfeeding of at least 
40%.  In addition, at 18 months, the mortality 
rate for the exclusively breastfed Zimbabwean 
infants, whether or not HIV-infected, was less 
than half that of the partially breastfed 
infants. [2]  A further study by the South 
African group in 2007 [4] (Coovadia 2007) 
succeeded in supporting HIV-infected mothers to 
exclusively breastfeed for six months to show a 
risk of transmission through breastfeeding of 
4%.  However, it should be noted that a lapse of 
3 days' mixed feeding was permitted in this 
definition of "exclusive breastfeeding".

Transmission of HIV through exclusive 
breastfeeding when HIV+ mothers receive antiretroviral therapy
More recently, there have been at least eight 
different studies done that show that where 
mothers receive effective antiretroviral regimens 
from early- mid pregnancy which is continued 
through the period of exclusive breastfeeding, up 
to 6 months, then the risk of transmission of HIV 
to their babies can be reduced to less than 1% 
[6-13]   The most persuasive study (research 
conducted by researchers from Harvard University 
in Botswana, Shapiro et al [12]) shows that the 
risk of transmission via EBF was 0.28%, and the 
only transmissions were in women who were not 
adherent to their medications.   A similar 
finding was found in another study from Zambia 
where mothers received full ART throughout the 
breastfeeding period, exclusively breastfed for 
the first six months and continued partial 
breastfeeding for 12 months.  There were no cases 
of transmission through breastfeeding for mothers 
who were adherent to their medications [14]

Where mothers receive ART, but where 
breastfeeding is not exclusive, then the risk of 
transmission through breastfeeding is about 5% [15]

The take-home message seems to be that the risk 
of HIV transmission to the breastfed baby can be 
almost NIL when three pre-conditions are fulfilled:
    * when HIV+ women receive the ART treatment 
they need for their own health and to prevent 
transmission of HIV to their babies, ie at least 
from the second and third trimester of pregnancy 
and throughout the whole period of breastfeeding 
(preferably for life, as currently recommended)
    * when HIV+ women are adherent to these medications, and
    * when breastfeeding is exclusive for the first six months of life


[1] Coutsoudis A, Pillay K, Spooner E, Kuhn L, 
Coovadia HM.   Influence of infant-feeding 
patterns on early mother-to-child transmission of 
HIV-1 in Durban, South Africa: a prospective 
cohort study. South African Vitamin A Study 
Group. Lancet. 1999 Aug 7;354(9177):471-6.
[2] Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, 
Marinda ET, Nathoo KJ, Moulton LH, Ward BJ, the 
ZVITAMBO study group and Humphrey JH. Early 
exclusive breastfeeding reduces the risk of 
postnatal HIV-1 transmission and increases 
HIV-free survival. AIDS 2005, 19:699708.
[3] Coutsoudis A, Pillay K, Kuhn L, Spooner E, 
Tsai W-Y, Coovadia HM for the South African 
Vitamin A Study Group.  Method of feeding and 
transmission of HIV-1 from mothers to children by 
15 months of age: prospective cohort study from 
Durban, South Africa.  AIDS 2001;15:379-387.
[4] Coovadia HM, Rollins NC, Bland RM, Little K, 
Coutsoudis A, Bennish ML, Newell 
M-L.  Mother-to-child transmission of HIV-1 
infection during exclusive breastfeeding in the 
first 6 months of life: an intervention cohort 
study. Lancet 2007 March 31;369:1107-16.
[5] Iliff PJ, Piwoz EG, Tavengwa NV, Zunguza CD, 
Marinda ET, Nathoo KJ, Moulton LH, Ward BJ, the 
ZVITAMBO study group and Humphrey JH. Early 
exclusive breastfeeding reduces the risk of 
postnatal HIV-1 transmission and increases 
HIV-free survival. AIDS 2005, 19:699708
[6] Palombi, L., M.C. Marazzi, A. Voetberg, and 
N.A. Magid. Treatment acceleration program and 
the experience of the DREAM program in prevention 
of mother-to-child transmission of HIV. AIDS 2007;21(Suppl 4): S65.71
[7] Kilewo, C., K. Karlsson, A. Massawe, et al. 
Prevention of mother-to-child transmission of 
HIV-1 through breast-feeding by treating infants 
prophylactically with lamivudine in Dar es 
Salaam,Tanzania: the Mitra Study. Journal of 
Acquired Immune Deficiency Syndrome 2008;48(3): 315.23.
[8] Kilewo, C., K. Karlsson, M. Ngarina, et al. 
Prevention of mother to child transmission of 
HIV-1 through breastfeeding by treating mothers 
with triple antiretroviral therapy in Dar es 
Salaam, Tanzania: the Mitra Plus study. Journal 
of Acquired Immune Deficiency Syndrome 2009;52(3): 406.16.
[9]Marazzi, M.C., K. Nielsen-Saines, P.E. 
Buonomi, et al. Increased infant human 
immunodeficiency virustype one free survival at 
one year of age in sub-Saharan Africa with 
maternal use of Highly Active Antiretroviral 
Therapy during breast-feeding. Pediatric 
Infectious Disease Journal 2009;28: 483.487.
[10]  Peltier, C.A., G.F. Ndayisaba, P. Lepage, 
et al. Breastfeeding with maternal antiretroviral 
therapy or formula feeding to prevent HIV 
postnatal mother-to child transmission in Rwanda. AIDS 2009;23:2415.23.
[11] Thomas TK, Masaba R, Borkowf CB, Ndivo R, 
Zeh C, Misore A, et al. Triple-Antiretroviral 
Prophylaxis to Prevent Mother-To-Child HIV 
Transmission through Breastfeeding-The Kisumu 
Breastfeeding Study, Kenya: A Clinical Trial. 
Plos Medicine 2011. Mar;8(3) e1001015.
[12] Shapiro RL, Hughes MD, Ogwu A, et al. 
Antiretroviral regimens in pregnancy and 
breast-feeding in Botswana. N Engl J Med 2010;362: 2282.94.
[13] Homsy J et al. Breastfeeding, 
mother-to-child HIV transmission, and mortality among infants born
to HIV-Infected women on highly active 
antiretroviral therapy in rural Uganda. Journal 
of Acquired Immune Deficiency Syndromes, 2010, 53(1):28.35.
[14] Silverman M, Preliminary Results of HIV 
Transmission Rates Using a Lopinavir/ritonavir 
(LPV/r, Aluvia) based regimen and the New WHO 
Breast Feeding Guidelines for PMTCT of HIV, 51st 
Interscience Conference on Antimicrobial Agents 
and Chemotherapy (ICAAC): Abstract H1-1153. Presented September 19, 2011
[15] Kesho Bora Study Group, Triple 
antiretroviral compared with zidovudine and 
single-dose nevirapine prophylaxis during 
pregnancy and breastfeeding for prevention of 
mother-to-child transmission of HIV-1 (Kesho Bora 
study): a randomised controlled trial, The Lancet 
2011; DOI:10.1016/S1473-3099(10)70288-7

____________________________________

Finally, at the beginning of this month 
WABA  published a Comprehensive Resource on 
International Policy on HIV and Breastfeeding, 
where you can find all the above facts and 
figures and a whole lot more background on the 
research and how HIV and breastfeeding has 
evolved over the years.  It can be downloaded 
at 
<http://www.waba.org.my/whatwedo/hcp/ihiv.htm#kit>http://www.waba.org.my/whatwedo/hcp/ihiv.htm#kit 
.    Please let me know if I can help you further.

Pamela Morrison IBCLC
Rustington, England
------------------------------------------

Date: Fri, 21 Dec 2012 07:41:13 -0500
From: germaine lambergs <[log in to unmask]>
Subject: sero conversion for infants.

Dear Lactnet, Can anyone direct me to the research that discusses the
sero conversion rate for infants that have HIV + mothers who
exclusively breastfeed their infants. thank you so much Germaine
lambergs.

             ***********************************************

Archives: http://community.lsoft.com/archives/LACTNET.html
To reach list owners: [log in to unmask]
Mail all list management commands to: [log in to unmask]
COMMANDS:
1. To temporarily stop your subscription write in the body of an email: set lactnet nomail
2. To start it again: set lactnet mail
3. To unsubscribe: unsubscribe lactnet
4. To get a comprehensive list of rules and directions: get lactnet welcome

ATOM RSS1 RSS2